Clinical Trials Browser

Interventional × L-BLP25 × Plasma cell × Clear all

NCT01423760 2016-10-06

Common Safety Follow-up Trial of Tecemotide (L-BLP25)

Phase NA Terminated

27 enrolled 7 charts

Plasma cellThoracic

Carcinoma, Non-Small-Cell Lung, Multiple Myeloma

NCT01094548 2016-02-22

Study of Tecemotide (L-BLP25) in Subjects With Slowly Progressive Multiple Myeloma With no Symptoms and Who Have Had no Chemotherapy

Phase 2 Completed

34 enrolled 12 charts

Multiple Myeloma